SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041640
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:34
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_aikidopharma.htm   iXBRL 10-Q 487280
2 CERTIFICATION f10q0621ex31-1_aikidopharma.htm EX-31.1 15948
3 CERTIFICATION f10q0621ex32-1_aikidopharma.htm EX-32.1 7093
  Complete submission text file 0001213900-21-041640.txt   2907371

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20210630.xsd EX-101.SCH 37806
5 XBRL CALCULATION FILE aiki-20210630_cal.xml EX-101.CAL 26512
6 XBRL DEFINITION FILE aiki-20210630_def.xml EX-101.DEF 158495
7 XBRL LABEL FILE aiki-20210630_lab.xml EX-101.LAB 334955
8 XBRL PRESENTATION FILE aiki-20210630_pre.xml EX-101.PRE 173011
9 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_aikidopharma_htm.xml XML 272421
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 211163623
SIC: 8731 Services-Commercial Physical & Biological Research